A Safety and Efficacy Study of BOTOX® in Korean Adults With Chronic Migraine
Phase 4
Completed
- Conditions
- Migraine Disorders
- Interventions
- Biological: botulinum toxin Type A
- First Posted Date
- 2014-05-26
- Last Posted Date
- 2016-05-27
- Lead Sponsor
- Allergan
- Target Recruit Count
- 280
- Registration Number
- NCT02147561
Spasticity Registry Evaluating Epidemiology, Treatment Patterns and Clinical Needs
Withdrawn
- Conditions
- Muscle Spasticity
- Interventions
- Other: No Intervention
- First Posted Date
- 2014-05-23
- Last Posted Date
- 2015-11-03
- Lead Sponsor
- Allergan
- Registration Number
- NCT02145650
OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity
Phase 3
Terminated
- Conditions
- Muscle SpasticityStroke
- Interventions
- Biological: onabotulinumtoxinADrug: placebo (normal saline)
- First Posted Date
- 2014-05-23
- Last Posted Date
- 2017-04-12
- Lead Sponsor
- Allergan
- Target Recruit Count
- 53
- Registration Number
- NCT02145676
Long-Term Study of OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity
Phase 3
Withdrawn
- Conditions
- Muscle SpasticityStroke
- Interventions
- Biological: onabotulinumtoxinA
- First Posted Date
- 2014-05-23
- Last Posted Date
- 2014-08-13
- Lead Sponsor
- Allergan
- Registration Number
- NCT02145689
Safety and Efficacy of Oxymetazoline HCl Cream 1.0% in Patients With Persistent Erythema Associated With Rosacea
Phase 3
Completed
- Conditions
- ErythemaRosacea
- Interventions
- First Posted Date
- 2014-05-07
- Last Posted Date
- 2019-11-18
- Lead Sponsor
- Allergan
- Target Recruit Count
- 445
- Registration Number
- NCT02132117
Retrospective Study of Incidence and Etiology of Reoperation After Primary Augmentation With Natrelle® Breast Implants
Completed
- Conditions
- Breast Implantation
- Interventions
- Device: BIOCELL™ Textured 410 Implant
- First Posted Date
- 2014-05-07
- Last Posted Date
- 2016-09-13
- Lead Sponsor
- Allergan
- Target Recruit Count
- 201
- Registration Number
- NCT02132572
Efficacy and Safety of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea
- First Posted Date
- 2014-05-06
- Last Posted Date
- 2019-11-18
- Lead Sponsor
- Allergan
- Target Recruit Count
- 440
- Registration Number
- NCT02131636
Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy
Phase 4
Completed
- Conditions
- Dry Eye Syndromes
- Interventions
- Drug: carboxymethylcellulose-based lubricant eye drops
- First Posted Date
- 2014-04-24
- Last Posted Date
- 2019-04-18
- Lead Sponsor
- Allergan
- Target Recruit Count
- 40
- Registration Number
- NCT02121847
A Safety and Efficacy Study of Dexamethasone Versus Laser Photocoagulation in Participants With Diabetic Macular Edema
Phase 3
Completed
- Conditions
- Macular Edema
- Interventions
- Procedure: Laser Photocoagulation
- First Posted Date
- 2014-04-23
- Last Posted Date
- 2020-11-17
- Lead Sponsor
- Allergan
- Target Recruit Count
- 284
- Registration Number
- NCT02121262
- Locations
- 🇨🇳
Wenzhou Ophthalmic Centre, Wenzhou, Zhejiang, China
🇵🇭Peregrine Eye and Laser Institute, Makati City, Metro Manila, Philippines
🇨🇳Beijing Hospital, Beijing, Beijing, China
A Safety and Efficacy Study of OPTIVE FUSION™ With VISMED® Multi for the Management of Dry Eye
Phase 4
Completed
- Conditions
- Dry Eye SyndromesKeratoconjunctivitis Sicca
- Interventions
- First Posted Date
- 2014-04-21
- Last Posted Date
- 2019-04-18
- Lead Sponsor
- Allergan
- Target Recruit Count
- 80
- Registration Number
- NCT02117687
© Copyright 2025. All Rights Reserved by MedPath